FDA NEWS

Discovery Laboratories receives notice of meeting with FDA regarding - CNBC
NEW YORK (Thomson Financial) - Discovery Laboratories Inc. Thursday said it received notice of a meeting with the Food and Drug Administration to confirm the company's approach to addressing items necessary to gain U.S. marketing approval of its drug
Source: www.cnbc.com

Pfizer Starts Media Ad Blitz to Address Smoking Drug Concerns - Bloomberg
May 29 (Bloomberg) -- Pfizer Inc. , the world's biggest drugmaker, will run newspaper ads and send letters to doctors to quell concerns about its quit-smoking treatment Chantix, linked to suicides, seizures, and traffic accidents. The New York-based
Source: www.bloomberg.com

FDA reviewing Pfizer smoking-cessation drug - Reuters
WASHINGTON (Reuters) - The Food and Drug Administration is taking a closer look at Pfizer Inc's (PFE.N: Quote , Profile , Research ) anti-smoking drug Chantix after reports of patients experiencing hundreds of serious problems, an agency official
Source: www.reuters.com

FDA takes another look at prescription warnings - Baltimore Sun
WASHINGTON - Federal health officials proposed yesterday streamlining prescription drug warnings for women who are pregnant or nursing, to make it easier for physicians and patients to determine whether it's safe to take the medicines. The Food and
Source: www.baltimoresun.com

Drug Labeling Aimed at Pregnant Women May Change - FOX News
Doctors may soon get a new way to tell which medications are safe for women to use during pregnancy and when they breastfeed. Today, prescription drugs carry a code in the fine print of their labels that rank their pregnancy safety: Category A means
Source: www.foxnews.com

Figure Skater Peggy Fleming Teams With HealthSaver: The Impact of Diet - Forbes
NORWALK, Conn., May 29 /PRNewswire/ -- Complementary and alternative medicine is a diverse group of health care practices not presently considered to be a part of traditional medicine. According to the U.S. Department of Health and Human Services
Source: www.forbes.com

FDA says Glaxo drug fails to control bleeding - San Francisco Gate
An experimental drug from GlaxoSmithKline does not significantly lower bleeding in patients with a rare blood disorder, according to the Food and Drug Administration. British drugmaker Glaxo is seeking approval for Promacta to treat a disorder that
Source: www.sfgate.com

HGS to Test Lupus Drug As an MS Treatment - Washington Post
Human Genome Sciences told analysts yesterday that it was moving forward on several biotechnology drugs and that it planned to begin testing its experimental lupus drug as a treatment for multiple sclerosis. "One of the knocks on this company is that
Source: www.washingtonpost.com